Treace Medical Concepts

Treace Medical Concepts

Health Care Equipment & Supplies
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

$291.4M

Market Cap • 9/28/2026

2014

(12 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

4,3

P/S

1,4

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,1

EPS

—

Market Cap

Market Cap

291,4M

EV

314,9M

EV/Revenue

1,5

EV/EBITDA

-6,9

EV/EBIT

-5,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,1%

Total Yield

0,1%

Payout

0%

Retained Earnings

-282,8M

Profitability

Gross Margin

79,5%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

8,9%

Capex/Revenue

5,1%

Capex/D&A

125%

Capex/OCF

-71,8%

SBC/OCF

—

% PPE

21,9%

% Goodwill

7,1%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

21,4%

CAGR Op. Income 5Y

95,5%

CAGR Net Income 5Y

34,9%

CAGR EPS 5Y

36%

CAGR OCF 5Y

19,7%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,9

Quick Ratio

1,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium